Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
BACKGROUND: Identifying host determinants associated with HIV reservoir size and timing of viral rebound after an analytic treatment interruption (ATI) is an important step in the search for an HIV functional cure. We performed a pooled analysis of 103 participants from 4 AIDS Clinical Trials Group...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pathogens and Immunity
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761077/ https://www.ncbi.nlm.nih.gov/pubmed/29333522 http://dx.doi.org/10.20411/pai.v2i3.222 |
_version_ | 1783291495309115392 |
---|---|
author | Park, You Jeong Etemad, Behzad Ahmed, Hayat Naranbhai, Vivek Aga, Evgenia Bosch, Ronald J. Mellors, John W. Kuritzkes, Daniel R. Para, Michael Gandhi, Rajesh T. Carrington, Mary Li, Jonathan Z. |
author_facet | Park, You Jeong Etemad, Behzad Ahmed, Hayat Naranbhai, Vivek Aga, Evgenia Bosch, Ronald J. Mellors, John W. Kuritzkes, Daniel R. Para, Michael Gandhi, Rajesh T. Carrington, Mary Li, Jonathan Z. |
author_sort | Park, You Jeong |
collection | PubMed |
description | BACKGROUND: Identifying host determinants associated with HIV reservoir size and timing of viral rebound after an analytic treatment interruption (ATI) is an important step in the search for an HIV functional cure. We performed a pooled analysis of 103 participants from 4 AIDS Clinical Trials Group ATI studies to identify the association between HLA class I alleles with HIV reservoir size and viral rebound timing. METHODS: Total HIV DNA and cell-associated HIV RNA (CA-RNA) were quantified in pre-ATI peripheral blood mononuclear cell samples, and residual plasma viremia was measured using the single-copy assay. HLA class I typing was performed, and we generated an odds ratio (OR) of predicted HLA effect on HIV viremia control for each individual and compared this with time to viral rebound, and levels of HIV DNA and CA-RNA. RESULTS: There was no significant association between the HLA ORs and levels of HIV DNA or CA-RNA, but carriage of protective HLA-B alleles (lower OR scores) was associated with delayed viral rebound (P = 0.02). Higher OR scores at the HLA-C locus were associated with longer duration of ART treatment (P = 0.02) and this trend was also seen with the combined OR score (P < 0.01). Individuals with protective HLA-B alleles had delayed viral rebound after treatment interruption that was not explained by differences in baseline reservoir size. CONCLUSIONS: The results indicate the vital role of cellular host immunity in preventing HIV rebound and the importance of taking into account the HLA status of study participants being evaluated in trials for an HIV cure. |
format | Online Article Text |
id | pubmed-5761077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Pathogens and Immunity |
record_format | MEDLINE/PubMed |
spelling | pubmed-57610772018-01-10 Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption Park, You Jeong Etemad, Behzad Ahmed, Hayat Naranbhai, Vivek Aga, Evgenia Bosch, Ronald J. Mellors, John W. Kuritzkes, Daniel R. Para, Michael Gandhi, Rajesh T. Carrington, Mary Li, Jonathan Z. Pathog Immun Research Article BACKGROUND: Identifying host determinants associated with HIV reservoir size and timing of viral rebound after an analytic treatment interruption (ATI) is an important step in the search for an HIV functional cure. We performed a pooled analysis of 103 participants from 4 AIDS Clinical Trials Group ATI studies to identify the association between HLA class I alleles with HIV reservoir size and viral rebound timing. METHODS: Total HIV DNA and cell-associated HIV RNA (CA-RNA) were quantified in pre-ATI peripheral blood mononuclear cell samples, and residual plasma viremia was measured using the single-copy assay. HLA class I typing was performed, and we generated an odds ratio (OR) of predicted HLA effect on HIV viremia control for each individual and compared this with time to viral rebound, and levels of HIV DNA and CA-RNA. RESULTS: There was no significant association between the HLA ORs and levels of HIV DNA or CA-RNA, but carriage of protective HLA-B alleles (lower OR scores) was associated with delayed viral rebound (P = 0.02). Higher OR scores at the HLA-C locus were associated with longer duration of ART treatment (P = 0.02) and this trend was also seen with the combined OR score (P < 0.01). Individuals with protective HLA-B alleles had delayed viral rebound after treatment interruption that was not explained by differences in baseline reservoir size. CONCLUSIONS: The results indicate the vital role of cellular host immunity in preventing HIV rebound and the importance of taking into account the HLA status of study participants being evaluated in trials for an HIV cure. Pathogens and Immunity 2017-11-27 /pmc/articles/PMC5761077/ /pubmed/29333522 http://dx.doi.org/10.20411/pai.v2i3.222 Text en © Pathogens and Immunity 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Research Article Park, You Jeong Etemad, Behzad Ahmed, Hayat Naranbhai, Vivek Aga, Evgenia Bosch, Ronald J. Mellors, John W. Kuritzkes, Daniel R. Para, Michael Gandhi, Rajesh T. Carrington, Mary Li, Jonathan Z. Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title | Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title_full | Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title_fullStr | Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title_full_unstemmed | Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title_short | Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption |
title_sort | impact of hla class i alleles on timing of hiv rebound after antiretroviral treatment interruption |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761077/ https://www.ncbi.nlm.nih.gov/pubmed/29333522 http://dx.doi.org/10.20411/pai.v2i3.222 |
work_keys_str_mv | AT parkyoujeong impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT etemadbehzad impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT ahmedhayat impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT naranbhaivivek impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT agaevgenia impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT boschronaldj impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT mellorsjohnw impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT kuritzkesdanielr impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT paramichael impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT gandhirajesht impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT carringtonmary impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption AT lijonathanz impactofhlaclassiallelesontimingofhivreboundafterantiretroviraltreatmentinterruption |